Clinical Trial

Observation of the Therapeutic Effect of Fire Needle on Upper Limb Function in Stroke Patients

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 24, 2025 (before its estimated September 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
Objective: To explore the clinical efficacy of different needling strategies with moxibustion needles on upper limb function in post-stroke patients. Method: 105 patients with upper limb dysfunction after stroke were randomly divided into an extensor treatment group, a flexor treatment group, and a control group, with 35 patients in each group. Patients in the extensor treatment group were treated with extensor group moxibustion, patients in the flexor treatment group were treated with flexor group moxibustion, and patients in the control group were treated with conventional moxibustion. Observe the upper limb movement trajectory, surface electromyographic signals (sEMG) of extensor and flexor muscle groups, MAS scale scores, and FMA-UE scores of two groups of patients under specific tasks detected by a three-dimensional motion capture system before and after treatment, and determine the clinical efficacy. Result: Moxibustion therapy with moxibustion is helpful in improving upper limb dysfunction in stroke patients, safe and reliable, and worthy of application. The efficacy of needling the flexor muscle group with moxibustion is better than that of needling the extensor muscle group and conventional acupuncture, providing certain evidence and guidance for the selection of moxibustion sites in clinical practice.
Trial Details
NCT Number NCT07140406
Lead Sponsor Qilu Hospital of Shandong University
Conditions Cerebral Infarction
Enrollment 105 participants
Start Date 2023-12-02
Primary Completion 2025-09-30 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2025-08-24